HCT CHART READY TO BREAKOUT coming off a triple bottom, page-290

Target sales were quoted not actual sales and these were provided by the US rep. HCT can only be guided by what their representative advises. During that period there were a lot of uncertainties which effected the targeted sales that were provided.

How do you know they did not have any proof at the time of the effectiveness of their Natsheild? They may have had lab test done in Malaysia we dont know this. Ultimately after the statement it was tested in the UK lab but what if they had already done test prior to this? All these are unknown quantities at this stage and everyone on HC is ASSUMING THINGS. The best thing to do is wait and see what transpires.

HCT has some very interesting products in the Low GI space and has a solid cashflow from it supplements business.

IMO the current market cap certainly does not reflect the potential especially the collagen deal with the Chinese.

Even if there were adverse finding and currently it is an if then company still has a solid core business and plenty of upside and a low market cap.